https://www.selleckchem.com/products/U0126.html
0% [1/25], and dermatologic 1.5% [2/131]). There were no significant differences among dogs with (n=37) or without potential AEs (n=94) in regards to ****, age, body weight, or dosage of MMF (P= .06, .13, .24, and .26, respectively). In the dogs administered MMF, GI AEs were most common. Since potential hematologic and dermatologic AEs developed in a few dogs, clinicians should be aware of these when prescribing MMF to dogs with immune-mediated disease. In the dogs administered MMF, GI AEs were most common. Since potential hematologic and
כמו
תגובה
לַחֲלוֹק
